- abnormal urination / IMPC
- decreased circulating triglyceride level / IMPC
- decreased hemoglobin content / IMPC
- decreased B cell number / IMPC
- decreased T cell number / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- decreased mature B cell number / IMPC
- decreased IgG1 level / IMPC
- preweaning lethality, complete penetrance / IMPC
B6Dnk;B6N-Pknox1Gt(EUCJ0079d10)Hmgu/Ieg
Status | Available to order |
EMMA ID | EM:04608 |
International strain name | B6Dnk;B6N-Pknox1Gt(EUCJ0079d10)Hmgu/Ieg |
Alternative name | EUCJ0079_D10 |
Strain type | Gene-trap |
Allele/Transgene symbol | Pknox1Gt(EUCJ0079d10)Hmgu |
Gene/Transgene symbol | Pknox1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | This mouse line originates from EUCOMM ES clone EUCJ0079_D10. For further details on the construction of this clone see the page at HTGT. Removal of the targeting cassette using Flp recombinase is required to convert the targeted into a conditional allele. Click here for more information on EUCOMM final vectors. |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous C57BL/6Dnk, wild-type C57BL/6Dnk |
Stage of embryos | 2-cell |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased mean corpuscular hemoglobin concentration / IMPC
- abnormal urination / IMPC
- decreased IgG1 level / IMPC
- decreased hemoglobin content / IMPC
- decreased mature B cell number / IMPC
- preweaning lethality, complete penetrance / IMPC
- decreased B cell number / IMPC
- decreased T cell number / IMPC
- decreased circulating triglyceride level / IMPC
MGI phenotypes (allele matching)
- no phenotypic analysis / MGI
MGI phenotypes (gene matching)
- decreased hematocrit / MGI
- abnormal erythropoiesis / MGI
- abnormal liver development / MGI
- decreased body weight / MGI
- abnormal eye development / MGI
- small lens / MGI
- anemia / MGI
- absent mesoderm / MGI
- failure of primitive streak formation / MGI
- decreased embryo size / MGI
- edema / MGI
- thymus hypoplasia / MGI
- hemorrhage / MGI
- abnormal embryonic tissue morphology / MGI
- abnormal extraembryonic tissue morphology / MGI
- abnormal eye morphology / MGI
- abnormal pluripotent precursor cell morphology / MGI
- abnormal blood cell morphology/development / MGI
- no phenotypic analysis / MGI
- pallor / MGI
- embryonic growth retardation / MGI
- abnormal prenatal growth/weight/body size / MGI
- decreased fetal size / MGI
- increased double-negative T cell number / MGI
- abnormal retinal pigment epithelium morphology / MGI
- decreased percent body fat/body weight / MGI
- decreased angiogenesis / MGI
- abnormal retinal neuronal layer morphology / MGI
- increased T cell apoptosis / MGI
- decreased single-positive T cell number / MGI
- decreased erythroid progenitor cell number / MGI
- increased nucleated erythrocyte cell number / MGI
- decreased birth body size / MGI
- perinatal lethality, complete penetrance / MGI
- embryonic lethality, complete penetrance / MGI
- embryonic lethality between implantation and somite formation, complete penetrance / MGI
- lethality throughout fetal growth and development, complete penetrance / MGI
- abnormal visceral endoderm morphology / MGI
- absent anterior visceral endoderm / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).